cipaglucosidase alfa in combination with miglustat (Pombiliti® in combination with Opfolda®)
HSE100038
25027
cipaglucosidase alfa in combination with miglustat
Pombiliti® in combination with Opfolda®
Amicus Therapeutics Europe Limited
04/04/2025
20/03/2023
HSE Approval Letter Issued to Applicant
05/08/2025
Proposal from Applicant Under Review
21/07/2025
Awaiting Proposal from Applicant
10/07/2025
Applicant Meeting Held with CPU
10/07/2025
Rapid Review Completed
02/05/2025
Pricing and Reimbursement Application Complete
04/04/2025
Rapid Review Commissioned
31/03/2025